Apogee Therapeutics has begun dosing healthy volunteers in a Phase 1 clinical trial of APG808, the company’s anti-inflammatory injection…
Articles by Marisa Wexler, MS
Scientists at NextCure have developed a monoclonal antibody targeting the protein VSTM-1, which the company hopes to develop…
Treatment with the anti-inflammatory medication eblasakimab opened the airways of lung samples from people with chronic obstructive pulmonary disorder…
The U.S. Food and Drug Administration (FDA) has approved ReAlta Life Sciences’ request to launch a Phase 2 clinical trial…
The bacterium Stenotrophomonas maltophilia in the lungs is significantly associated with a higher risk of death and hospitalization due to…
After hospitalization due to chronic obstructive pulmonary disease (COPD) exacerbation, patients who live in rural areas and/or have to…
In the U.S., many people with diagnosed or probable chronic obstructive pulmonary disease (COPD) at higher risk of disease…
The U.S. Food and Drug Administration (FDA) has issued a warning letter to AstraZeneca for making false or misleading…
Verona Pharma has filed an application asking the U.S. Food and Drug Administration (FDA) to approve inhaled ensifentrine…
People with chronic obstructive pulmonary disease (COPD) tend to experience worsening symptoms at times when levels of pollution in…